Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (241-250 of 276) with videos related to

Pageof 28
Sort By:
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
Nature Communications|February 8, 2023
A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritisYibo He, Changrong Ge, Àlex Moreno-Giró, et al.
Frontiers in Immunology|January 1, 2025
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infectionLisan H Kuijper, Christine Kreher, George Elias, et al.
Science Advances|February 9, 2022
Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activationTheresa Kissel, Changrong Ge, Lise Hafkenscheid, et al.
European Journal of Immunology|March 12, 2026
Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS-CoV-2 VaccinationLaura Fernandez Blanco, Lisan H Kuijper, Laura Y L Kummer, et al.
European Journal of Neurology|September 5, 2024
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseasesKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 6, 2022
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or FingolimodVirginia Palomares Cabeza, Laura Y L Kummer, Luuk Wieske, et al.
The Lancet. Rheumatology|August 16, 2021
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studiesLaura Boekel, Maurice Steenhuis, Femke Hooijberg, et al.
JCI Insight|February 22, 2023
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding grooveTeresa Tsakok, Jake Saklatvala, Theo Rispens, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2023
CD5L is a canonical component of circulatory IgMNienke Oskam, Maurits A den Boer, Marie V Lukassen, et al.
Pageof 28

Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
Nature Communications|February 8, 2023
A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritisYibo He, Changrong Ge, Àlex Moreno-Giró, et al.
Frontiers in Immunology|January 1, 2025
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infectionLisan H Kuijper, Christine Kreher, George Elias, et al.
Science Advances|February 9, 2022
Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activationTheresa Kissel, Changrong Ge, Lise Hafkenscheid, et al.
European Journal of Immunology|March 12, 2026
Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS-CoV-2 VaccinationLaura Fernandez Blanco, Lisan H Kuijper, Laura Y L Kummer, et al.
European Journal of Neurology|September 5, 2024
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseasesKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 6, 2022
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or FingolimodVirginia Palomares Cabeza, Laura Y L Kummer, Luuk Wieske, et al.
The Lancet. Rheumatology|August 16, 2021
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studiesLaura Boekel, Maurice Steenhuis, Femke Hooijberg, et al.
JCI Insight|February 22, 2023
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding grooveTeresa Tsakok, Jake Saklatvala, Theo Rispens, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2023
CD5L is a canonical component of circulatory IgMNienke Oskam, Maurits A den Boer, Marie V Lukassen, et al.
Pageof 28